๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anti-CD20 Therapy for Chronic Lymphocytic Leukemia-associated Autoimmune Diseases

โœ Scribed by Zaja, Francesco; Vianelli, Nicola; Sperotto, Alessandra; Patriarca, Francesca; Tani, Monica; Marin, Luciana; Tiribelli, Mario; Candoni, Anna; Baccarani, Michele; Fanin, Renato

Book ID
126478589
Publisher
Informa plc
Year
2003
Tongue
English
Weight
449 KB
Volume
44
Category
Article
ISSN
1042-8194

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Rituximab therapy for chronic lymphocyti
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
โœ Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 2 views

Autoimmune hemolytic anemia (AIHA) is a well-known complication of chronic lymphocytic leukemia (CLL). In recent years the anti-CD20 monoclonal antibody rituximab has been used for the therapy of steroid-refractory AIHA and autoimmune thrombocytopenia, either idiopathic or in association with CLL. W